In conclusion, the current findings reveal that p16, CDH1, RUNX3, MLH1, RASSF1A, p15, APC, GSTP1, Reprimo, or MGMTpromoter methylation is associated with blood samples of patients with GC. Here, MLH1 is linked to gastric cancer.